Table 1.
Demographics and clinical characteristics of IF patients at the start of IVS.
| Variable | Total (n = 98) | |
|---|---|---|
| Age (years) | Median (IQR) | 54.8 (43.1; 65) |
| Gender | Female (%) | 54 (55) |
| Weight (kg) | Median (IQR) | 61 (52.2; 72) |
| BMI (kg/m2) | Median (IQR) | 24.1 (21.7; 31.9) |
| Mechanism of IF | SBS (%) | 77 (78.6) |
| Mot (%) | 9 (9.1) | |
| O (%) | 5 (5.1) | |
| MD (%) | 4 (4.1) | |
| F (%) | 3 (3.1) | |
| Severity of IF (max) | FE (%) | 5 (5.1) |
| PN1 (≤1 L) | 9 (9.1) | |
| PN2 (1–2 L) | 46 (46.9) | |
| PN3 (2–3 L) | 16 (16.3) | |
| PN4 (>3 L) | 22 (22.4) | |
| IVS duration (weeks) | Median (IQR) | 30.8 (13.7; 58.3) |
| FU duration (weeks) | Median (IQR) | 40.1 (14.7; 69.9) |
Mechanism and severity (daily mean of the maximum volume infused per week) of IF were defined according to ESPEN guidelines. Abbreviations: fistula (F), fluids and electrolytes (FE), follow-up (FU), intestinal failure (IF), intravenous support (IVS), mucosal disease (MD), motility disorder (Mot), obstruction (O), parenteral nutrition (PN), and short bowel syndrome (SBS).